Skip to content
10-Q

Quarterly Report

ALEXION PHARMACEUTICALS, INC.

0000899866-20-000074

← back to feed
Filed
Jul 30, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 28, 2020 219.17M sh
Shares Diluted Q2 2020 · Jun 30, 2020 220.6M sh
Shares Diluted Q2 2020 · Jun 30, 2020 221.1M sh
Shares Diluted Q2 2020 · Jun 30, 2019 225.6M sh
Shares Diluted Q2 2020 · Jun 30, 2019 225.7M sh
Stock Repurchased Q2 2020 · Jun 30, 2020 $360.8M
Stock Repurchased Q2 2020 · Jun 30, 2019 $48.9M
Capex Q2 2020 · Jun 30, 2020 $18.4M
Capex Q2 2020 · Jun 30, 2019 $82.8M
Operating Cash Flow Q2 2020 · Jun 30, 2020 $1.34B
Operating Cash Flow Q2 2020 · Jun 30, 2019 $968.3M
Long Term Debt Q2 2020 · Jun 30, 2020 $2.31B
Long Term Debt Q2 2020 · Dec 31, 2019 $2.38B
Short Term Debt Q2 2020 · Jun 30, 2020 $126.8M
Short Term Debt Q2 2020 · Dec 31, 2019 $126.7M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $2.83B
Cash And Equivalents Q2 2020 · Dec 31, 2019 $2.69B
Cash And Equivalents Q2 2020 · Jun 30, 2019 $1.98B
Stockholders Equity Q2 2020 · Jun 30, 2020 $10.49B
Stockholders Equity Q2 2020 · Mar 31, 2020 $11.75B
Stockholders Equity Q2 2020 · Dec 31, 2019 $11.27B
Stockholders Equity Q2 2020 · Jun 30, 2019 $10.16B
Stockholders Equity Q2 2020 · Mar 31, 2019 $9.71B
Stockholders Equity Q2 2020 · Dec 31, 2018 $9.17B
Current Liabilities Q2 2020 · Jun 30, 2020 $1.12B
Current Liabilities Q2 2020 · Dec 31, 2019 $1.19B
Total Liabilities Q2 2020 · Jun 30, 2020 $6.21B
Total Liabilities Q2 2020 · Dec 31, 2019 $6.27B
Current Assets Q2 2020 · Jun 30, 2020 $5.37B
Current Assets Q2 2020 · Dec 31, 2019 $5.08B
Total Assets Q2 2020 · Jun 30, 2020 $16.7B
Total Assets Q2 2020 · Dec 31, 2019 $17.54B
Eps Diluted Q2 2020 · Jun 30, 2020 −$4.84
Eps Diluted Q2 2020 · Jun 30, 2020 −$2.31
Eps Diluted Q2 2020 · Jun 30, 2019 $2.04
Eps Diluted Q2 2020 · Jun 30, 2019 $4.64
Eps Basic Q2 2020 · Jun 30, 2020 −$4.84
Eps Basic Q2 2020 · Jun 30, 2020 −$2.31
Eps Basic Q2 2020 · Jun 30, 2019 $2.05
Eps Basic Q2 2020 · Jun 30, 2019 $4.68
Sga Expense Q2 2020 · Jun 30, 2020 $301.4M
Sga Expense Q2 2020 · Jun 30, 2020 $621.3M
Sga Expense Q2 2020 · Jun 30, 2019 $299.3M
Sga Expense Q2 2020 · Jun 30, 2019 $580.8M
Net Income Q2 2020 · Jun 30, 2020 −$1.07B
Net Income Q2 2020 · Jun 30, 2020 −$510.5M
Net Income Q2 2020 · Jun 30, 2019 $459.8M
Net Income Q2 2020 · Jun 30, 2019 $1.05B
Operating Income Q2 2020 · Jun 30, 2020 −$1.37B
Operating Income Q2 2020 · Jun 30, 2020 −$674.7M
Operating Income Q2 2020 · Jun 30, 2019 $532.6M
Operating Income Q2 2020 · Jun 30, 2019 $1.05B
Revenue Q2 2020 · Jun 30, 2020 $1.44B
Revenue Q2 2020 · Jun 30, 2020 $2.89B
Revenue Q2 2020 · Jun 30, 2019 $1.2B
Revenue Q2 2020 · Jun 30, 2019 $2.34B